Protein-Folding Artificial Intelligence (AI) Platform Market Report 2026

Protein-Folding Artificial Intelligence (AI) Platform Market Overview

• Protein-Folding Artificial Intelligence (AI) Platform market size has reached to $1.88 billion in 2025 • Expected to grow to $7.58 billion in 2030 at a compound annual growth rate (CAGR) of 32.2% • Growth Driver: Rising Demand For Personalized Medicine Driving The Market Growth Due To Advances In Genomic Technologies And Increasing Approval Of Targeted Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Protein-Folding Artificial Intelligence (AI) Platform Market?

A protein-folding artificial intelligence (AI) platform is a computational system that uses artificial intelligence and machine learning algorithms to predict the three-dimensional structure of proteins from their amino acid sequences. These platforms analyze biological data, structural databases, and physicochemical properties to model protein folding, stability, and interactions with high speed and accuracy. The main components of protein-folding artificial intelligence (AI) platform include software, hardware, and services. Software refers to platforms that leverage AI algorithms to predict protein folding patterns and three-dimensional structures, accelerating drug discovery and biological research. These solutions are deployed through on-premises and cloud models. They are applied in drug discovery, disease research, personalized medicine, biotechnology, academic research, and other applications, and while the end users including pharmaceutical and biotechnology companies, research institutes, healthcare providers, and other end users.

What Is The Protein-Folding Artificial Intelligence (AI) Platform Market Growth Forecast?

The protein-folding artificial intelligence (AI) platform market size is expected to see exponential growth in the next few years. It will grow to $7.58 billion in 2030 at a compound annual growth rate (CAGR) of 32.2%. The growth in the forecast period can be attributed to integration of ai and deep learning for protein folding, expansion of cloud-based bioinformatics platforms, investment in specialized ai accelerators, growing academic and biotech research initiatives, demand for faster drug discovery cycles. Major trends in the forecast period include ai-driven protein structure prediction, high-performance computing integration, automated molecular modeling, cloud-based bioinformatics platforms, predictive drug discovery analytics.

Global Protein-Folding Artificial Intelligence (AI) Platform Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: On-Premises, Cloud 3) By Application: Drug Discovery, Disease Research, Personalized Medicine, Biotechnology, Academic Research, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Healthcare Providers, Other End Users Subsegments: 1) By Software: Protein Structure Prediction Platforms, Molecular Modeling And Simulation Software, Bioinformatics Analysis Software, Data Visualization And Interpretation Tools, Machine Learning And Deep Learning Frameworks, Workflow Management And Automation Software 2) By Hardware: High Performance Computing Systems, Graphics Processing Units, Central Processing Units, Data Storage Systems, High Speed Networking Infrastructure, Specialized Artificial Intelligence Accelerators 3) By Services: Consulting And Advisory Services, System Integration Services, Cloud And Infrastructure Management Services, Model Development And Validation Services, Data Annotation And Curation Services, Maintenance And Technical Support Services

What Are The Drivers Of The Protein-Folding Artificial Intelligence (AI) Platform Market?

The growing personalized medicine adoption is expected to propel the growth of the protein-folding artificial intelligence (AI) platform market going forward. Personalized medicine is an approach that customizes healthcare and therapies based on a patient’s unique biological and personal characteristics. The use of personalized medicine is increasing due to advances in genomic technologies, which allow healthcare providers to analyze a patient’s genetic information quickly and accurately, enabling more targeted and effective treatments. A protein-folding artificial intelligence platform enables personalized medicine by predicting patient-specific protein structures to guide targeted drug selection and optimized therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the growing personalized medicine adoption is driving the growth of the protein-folding artificial intelligence (AI) platform industry. The growing research and development activities are expected to propel the growth of the protein-folding artificial intelligence (AI) platform market going forward. Research and development (R&D) activities refer to systematic efforts to create, improve, or innovate products, processes, or services through the application of scientific and technical knowledge. Increasing research and development activities are rising due to intensifying global competition, as organizations invest in innovation and advanced technologies to differentiate themselves and achieve sustainable long-term growth. Research and development activities help the protein-folding AI platform by enabling the creation and refinement of algorithms, improving protein structure predictions, and accelerating the discovery of novel therapeutics. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, the UK government’s net spending on research and development (R&D) increased to £17.4 billion ($22.1 billion) in 2023, up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% rise. Therefore, the growing research and development activities are driving the growth of the protein-folding artificial intelligence (AI) platform industry.

Key Players In The Global Protein-Folding Artificial Intelligence (AI) Platform Market

Major companies operating in the protein-folding artificial intelligence (AI) platform market are Schrodinger Inc., XtalPi Inc., Isomorphic Labs Limited, Recursion Pharmaceuticals Inc., Nabla Bio Inc., Arzeda Corporation, Evozyne, ProteinQure Inc., Genesis Therapeutics Inc., Cradle Bio Inc., Profluent Inc., Evaxion Biotech A/S, Iambic Therapeutics Inc., Insilico Medicine Inc., Insitro Inc., Levitate Bio Inc., Shiru Inc., Tamarind Bio, Archon Biosciences, Neoncorte Bio, and Generate Biomedicines Inc.

What Are Latest Mergers And Acquisitions In The Protein-Folding Artificial Intelligence (AI) Platform Market?

In December 2025, Isomorphic Labs Ltd., a UK-based artificial intelligence and drug-discovery company that builds on protein-folding AI technology, partnered with Eli Lilly and Novartis to advance AI-designed drug discovery and accelerate the development of novel therapeutics. The partnership aims to leverage AI-driven molecular design, enhance drug target identification, and expedite the discovery of innovative medicines. Eli Lilly and Company is a US-based pharmaceutical company, and Novartis AG is a Switzerland-based pharmaceutical company, both specializing in the development of therapeutics across multiple disease areas.

Regional Insights

North America was the largest region in the protein-folding artificial intelligence (AI) platform market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Protein-Folding Artificial Intelligence (AI) Platform Market?

The protein-folding artificial intelligence (AI) platform market consists of revenues earned by entities by providing services such as structure prediction modeling, molecular interaction analysis, drug target identification support, protein stability, and mutation impact assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein-folding artificial intelligence (AI) platform market also includes sales of high-performance GPU servers, AI-optimized tensor processing units (TPUs), advanced data storage systems, and high-speed networking infrastructure. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Protein-Folding Artificial Intelligence (AI) Platform Market Report 2026?

The protein-folding artificial intelligence (ai) platform market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the protein-folding artificial intelligence (ai) platform industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.